27 Mar 2020 Sanofi Pasteur and Translate Bio to Collaborate to Develop a Novel mRNA Vaccine Candidate Against COVID-19
26 Mar 2020 INOVIO Reports Positive Interim Phase 2 VGX-3100 Results In Patients with HPV-associated Anal Dysplasia
26 Mar 2020 Sorrento Launches Novel I-Cell™ COVID-19 Cellular Vaccine Program
26 Mar 2020 Dynavax and CEPI Announce Collaboration to Support Global Effort to Develop a Vaccine for Coronavirus (COVID-19)
26 Mar 2020 SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
25 Mar 2020 Sartorius Supports the Development of the First Vaccine Candidate Against the Novel Coronavirus to Enter Clinical Trials
25 Mar 2020 Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech
24 Mar 2020 eTheRNA Launches an International Consortium and Starts Development of Cross-strain Protective CoV-2 mRNA Vaccine for High Risk Populations
24 Mar 2020 Ufovax successfully extended its Nanoparticle vaccine technology to SARS-CoV-2
24 Mar 2020 Dynavax and Clover Biopharmaceuticals Announce Research Collaboration to Evaluate Coronavirus (COVID-19) Vaccine Candidate with CpG 1018 Adjuvant
24 Mar 2020 Novavax’ NanoFlu Achieves All Primary Endpoints In Phase 3 Clinical Trial
23 Mar 2020 Hoth Therapeutics Announces Agreement to Joint Development for a Self-Assembling Vaccine (SAV) for the Potential Prevention of the Coronavirus (COVID-19)
23 Mar 2020 COVID-19 vaccine development
23 Mar 2020 Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy
19 Mar 2020 SELLAS Announces Positive Antigen-Specific Immune Response Data for Nelipepimut-S (NPS) in Women with Ductal Carcinoma In Situ (DCIS) of the Breast from Phase 2 VADIS Study
19 Mar 2020 Versatope Selects Influenza Vaccine Candidate for Clinical Development
19 Mar 2020 Entos Pharmaceuticals Is Developing a DNA Vaccine Against COVID-19 Using Its Fusogenix Nanomedicine Platform
19 Mar 2020 Pfizer Announces Top-Line Results from Phase 3 Study of 20-Valent Pneumococcal Conjugate Vaccine in Pneumococcal Vaccine-Naïve Adults Aged 18 Years or Older
17 Mar 2020 Moderna Announces First Participant Dosed in NIH-led Phase 1 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
17 Mar 2020 Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine
16 Mar 2020 BioNTech reports rapid progress on COVID-19 vaccine program to address global public health threat
15 Mar 2020 Johnson & Johnson Announces Collaboration with the Beth Israel Deaconess Medical Center to Accelerate COVID-19 Vaccine Development
13 Mar 2020 Medicago Announces Production of a Viable Vaccine Candidate for COVID-19
12 Mar 2020 Virometix Announces Initiation of Phase 1 Clinical Trial With Its V-306 Vaccine Candidate
11 Mar 2020 Novavax and Serum Institute of India to Develop and Commercialize Malaria Vaccine Candidate

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up